Abstract
Persons diagnosed with schizophrenia (SCZ) or bipolar I disorder (BPI) are at high risk for self-injurious behavior, suicidal ideation, and suicidal behaviors (SB). Characterizing associations between diagnosed health problems, prior pharmacological treatments, and polygenic scores (PGS) has potential to inform risk stratification. We examined self-reported SB and ideation using the Columbia Suicide Severity Rating Scale (C-SSRS) among 3,942 SCZ and 5,414 BPI patients receiving care within the Veterans Health Administration (VHA). These cross-sectional data were integrated with electronic health records (EHRs), and compared across lifetime diagnoses, treatment histories, follow-up screenings, and mortality data. PGS were constructed using available genomic data for related traits. Genome-wide association studies were performed to identify and prioritize specific loci. Only 20% of the veterans who reported SB had a corroborating ICD-9/10 EHR code. Among those without prior SB, more than 20% reported new-onset SB at follow-up. SB were associated with a range of additional clinical diagnoses, and with treatment with specific classes of psychotropic medications (e.g., antidepressants, antipsychotics, etc.). PGS for externalizing behaviors, smoking initiation, suicide attempt, and major depressive disorder were associated with SB. The GWAS for SB yielded no significant loci. Among individuals with a diagnosed mental illness, self-reported SB were strongly associated with clinical variables across several EHR domains. Analyses point to sequelae of substance-related and psychiatric comorbidities as strong correlates of prior and subsequent SB. Nonetheless, past SB was frequently not documented in health records, underscoring the value of regular screening with direct, in-person assessments, especially among high-risk individuals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All data sources are described in the manuscript and supplemental information. No new data were collected. Only data from existing cohorts of VA participants were analyzed, which have restricted access to protect the privacy of the study participants. The process for obtaining the GWAS summary statistics used in these analyses are described in the corresponding original GWAS publications.
Code availability
No custom algorithms or software was developed in this study. All code is available by request from the corresponding author. All primary analyses completed in R 4.2.2.
References
Wisqars W-BISQ. Reporting system. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (producer) https://www.cdc.gov/injury/wisqars/ Accessed September. 2020;25
Thompson M, Gibbs N. More U.S. soldiers have killed themselves than have died in the Afghan war. Why can’t the Army win the war on suicide? Time. 2012;180:22–31.
Tilstra AM, Simon DH, Masters RK. Trends in ‘deaths of despair’ among working-aged White and Black Americans, 1990–2017. Am J Epidemiol. 2021;190:1751–9.
Bachmann S. Epidemiology of suicide and the psychiatric perspective. Int J Environ Res Public Health. 2018;15:1425.
Bridge JA, Horowitz LM, Fontanella CA, Sheftall AH, Greenhouse J, Kelleher KJ, et al. Age-related racial disparity in suicide rates among US youths from 2001 through 2015. JAMA Pediatr. 2018;172:697–9.
Mullins N, Bigdeli TB, Børglum AD, Coleman JRI, Demontis D, Mehta D, et al. GWAS of suicide attempt in psychiatric disorders and association with major depression polygenic risk scores. Am J Psychiatry. 2019;176:651–60.
Levey DF, Polimanti R, Cheng Z, Zhou H, Nuñez YZ, Jain S, et al. Genetic associations with suicide attempt severity and genetic overlap with major depression. Transl Psychiatry. 2019;9:22.
Ruderfer DM, Walsh CG, Aguirre MW, Tanigawa Y, Ribeiro JD, Franklin JC, et al. Significant shared heritability underlies suicide attempt and clinically predicted probability of attempting suicide. Mol Psychiatry. 2020;25:2422–30.
Docherty AR, Shabalin AA, DiBlasi E, Monson E, Mullins N, Adkins DE, et al. Genome-wide association study of suicide death and polygenic prediction of clinical antecedents. Am J Psychiatry. 2020;177:917–27.
Karlsson Linnér R, Mallard TT, Barr PB, Sanchez-Roige S, Madole JW, Driver MN, et al. Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction. Nat Neurosci. 2021;24:1367–76.
Gaziano JM, Concato J, Brophy M, Fiore L, Pyarajan S, Breeling J, et al. Million veteran program: a mega-biobank to study genetic influences on health and disease. J Clin Epidemiol. 2016;70:214–23.
Harvey PD, Siever LJ, Huang GD, Muralidhar S, Zhao H, Miller P, et al. The genetics of functional disability in schizophrenia and bipolar illness: methods and initial results for VA cooperative study# 572. Am J Med Genet B Neuropsychiatr Genet. 2014;165:381–9.
Posner K, Brent D, Lucas C, Gould M, Stanley B, Brown G, et al. Columbia-suicide severity rating scale. New York, NY: Columbia University; 2008.
Bigdeli T, Fanous A, Li Y, Rajeevan N, Sayward F, Zhao H, et al. Genome-wide association studies of schizophrenia and bipolar disorder in a diverse cohort of US veterans. Biol Psychiatry. 2020;87:S178.
Harvey PD, Posner K, Rajeevan N, Yershova KV, Aslan M, Concato J. Suicidal ideation and behavior in US veterans with schizophrenia or bipolar disorder. J Psychiatr Res. 2018;102:216–22.
Aslan M, Radhakrishnan K, Rajeevan N, Sueiro M, Goulet JL, Li Y, et al. Suicidal ideation, behavior, and mortality in male and female US veterans with severe mental illness. J Affect Disord. 2020;267:144–52.
First MB, Spitzer RL, Gibbon M, Williams JBW User’s guide for the Structured clinical interview for DSM-IV axis I disorders SCID-I: clinician version. American Psychiatric Pub; Washington, DC 1997.
Posner K, Brent D, Lucas C, Gould M, Stanley B, Brown G, et al. Columbia-suicide severity rating scale (C-SSRS), vol 10. New York, NY: Columbia University Medical Center; 2008.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22–33.
Ashley-Koch AE, Kimbrel NA, Qin XJ, Lindquist JH, Garrett ME, Dennis MF, et al. Genome-wide association study identifies four pan-ancestry loci for suicidal ideation in the Million Veteran Program. PLoS Genet. 2023;19:e1010623.
Kimbrel NA, Ashley-Koch AE, Qin XJ, Lindquist JH, Garrett ME, Dennis MF, et al. A genome-wide association study of suicide attempts in the million veterans program identifies evidence of pan-ancestry and ancestry-specific risk loci. Mol Psychiatry. 2022;27:2264–72.
Liao KP, Sun J, Cai TA, Link N, Hong C, Huang J, et al. High-throughput multimodal automated phenotyping (MAP) with application to PheWAS. J Am Med Inf Assoc. 2019;26:1255–62.
Denny JC, Ritchie MD, Basford MA, Pulley JM, Bastarache L, Brown-Gentry K, et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations. Bioinformatics. 2010;26:1205–10.
Bigdeli TB, Voloudakis G, Barr PB, Gorman BR, Genovese G, Peterson RE, et al. Penetrance and pleiotropy of polygenic risk scores for schizophrenia, bipolar disorder, and depression among adults in the US veterans affairs health care system. JAMA Psychiatry. 2022;79:1092–101.
Klarin D, Damrauer SM, Cho K, Sun YV, Teslovich TM, Honerlaw J, et al. Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program. Nat Genet. 2018;50:1514–23.
1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526:68–74.
Das S, Forer L, Schönherr S, Sidore C, Locke AE, Kwong A, et al. Next-generation genotype imputation service and methods. Nat Genet. 2016;48:1284–7.
Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen W-M. Robust relationship inference in genome-wide association studies. Bioinformatics. 2010;26:2867–73.
Fang H, Hui Q, Lynch J, Honerlaw J, Assimes TL, Huang J, et al. Harmonizing genetic ancestry and self-identified race/ethnicity in genome-wide association studies. Am J Hum Genet. 2019;105:763–72.
Bigdeli TB, Genovese G, Georgakopoulos P, Meyers JL, Peterson RE, Iyegbe CO, et al. Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry. Mol Psychiatry. 2019. https://doi.org/10.1038/s41380-019-0517-y.
Peterson RE, Kuchenbaecker K, Walters RK, Chen C-Y, Popejoy AB, Periyasamy S, et al. Genome-wide association studies in ancestrally diverse populations: opportunities, methods, pitfalls, and recommendations. Cell. 2019;179:589–603.
Abraham G, Inouye M. Fast principal component analysis of large-scale genome-wide data. PLoS One. 2014;9:e93766.
Mullins N, Kang J, Campos AI, Coleman JRI, Edwards AC, Galfalvy H, et al. Dissecting the shared genetic architecture of suicide attempt, psychiatric disorders and known risk factors. Biol Psychiatry. 2021. https://doi.org/10.1016/j.biopsych.2021.05.029.
Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502–8.
Nievergelt CM, Maihofer AX, Klengel T, Atkinson EG, Chen C-Y, Choi KW, et al. International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci. Nat Commun. 2019;10:4558.
Mullins N, Forstner AJ, O’Connell KS, Coombes B, Coleman JRI, Qiao Z, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53:817–29.
Howard DM, Adams MJ, Clarke T-K, Hafferty JD, Gibson J, Shirali M, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22:343–52.
Liu M, Jiang Y, Wedow R, Li Y, Brazel DM, Chen F, et al. Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet. 2019;51:237–44.
Savage JE, Jansen PR, Stringer S, Watanabe K, Bryois J, de Leeuw CA, et al. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat Genet. 2018;50:912–9.
Lee SH, Wray NR, Goddard ME, Visscher PM. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet. 2011;88:294–305.
Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011;88:76–82.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.
Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.
Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190–1.
Schizophrenia Working Group of the Psychiatric Genomics, Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.
Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8:1826.
Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26:2336–7.
Lee CH, Eskin E, Han B. Increasing the power of meta-analysis of genome-wide association studies to detect heterogeneous effects. Bioinformatics. 2017;33:i379–i388.
Gamazon ER, Wheeler HE, Shah KP, Mozaffari SV, Aquino-Michaels K, Carroll RJ, et al. A gene-based association method for mapping traits using reference transcriptome data. Nat Genet. 2015;47:1091–8.
Barbeira, Dickinson AN, Bonazzola SP, Zheng R, Wheeler HE J, Torres JM, et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat Commun. 2018;9:1825.
Martin AR, Gignoux CR, Walters RK, Wojcik GL, Neale BM, Gravel S, et al. Human Demographic History Impacts Genetic Risk Prediction across Diverse Populations. Am J Hum Genet. 2017;100:635–49.
Duncan L, Shen H, Gelaye B, Meijsen J, Ressler K, Feldman M, et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat Commun. 2019;10:3328.
Gujral K, Bahraini N, Brenner LA, Van Campen J, Zulman DM, Illarmo S, et al. VA’s implementation of universal screening and evaluation for the suicide risk identification program in November 2020 -Implications for Veterans with prior mental health needs. PLoS ONE. 2023;18:e0283633.
DailyMed - CLOZAPINE tablet. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=883b5d43-0339-7dc1-f775-93791fb9b978. Accessed 28 Oct 2022.
Barr PB, Neale Z, Schulman J, Mullins N, Zhang J, Chorlian DB, et al. Clinical, genomic, and neurophysiological correlates of lifetime suicide attempts among individuals with alcohol dependence. medRxiv. 2023. https://doi.org/10.1101/2023.04.28.23289173.
Colbert SMC, Mullins N, Chan G, Meyers JL, Schulman J, Kuperman S, et al. Polygenic contributions to suicidal thoughts and behaviors in a sample ascertained for alcohol use disorders. Complex Psychiatry. 2023;9:11–23.
Lim KX, Rijsdijk F, Hagenaars SP, Socrates A, Choi SW, Coleman JRI, et al. Studying individual risk factors for self-harm in the UK Biobank: a polygenic scoring and Mendelian randomisation study. PLoS Med. 2020;17:e1003137.
Pardiñas AF, Holmans P, Pocklington AJ, Escott-Price V, Ripke S, Carrera N, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018;50:381–9.
Wegscheid ML, Anastasaki C, Hartigan KA, Cobb OM, Papke JB, Traber JN, et al. Patient-derived iPSC-cerebral organoid modeling of the 17q11.2 microdeletion syndrome establishes CRLF3 as a critical regulator of neurogenesis. Cell Rep. 2021;36:109315.
Lee JJ, Wedow R, Okbay A, Kong E, Maghzian O, Zacher M, et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat Genet. 2018;50:1112–21.
Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50:668–81.
Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107:234–56.
Blosnich JR, Montgomery AE, Dichter ME, Gordon AJ, Kavalieratos D, Taylor L, et al. Social determinants and military veterans’ suicide ideation and attempt: a cross-sectional analysis of electronic health record data. J Gen Intern Med. 2020;35:1759–67.
Acknowledgements
This research was supported by the Department of Veterans Affairs Cooperative Studies Program (CSP #572), the Million Veteran Program (MVP-000) and a Clinical Sciences Research and Development award (lK6BX003777). The MVP is supported by the Office of Research and Development, Department of Veterans Affairs. Full acknowledgements for CSP #572 and MVP are presented in the Supplement. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. TBB was supported by a 2019 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (#28276). This analysis uses data from the Externalizing Consortium, supported by the National Institute on Alcohol Abuse and Alcoholism (R01AA015416), and the National Institute on Drug Abuse (R01DA050721). Additional funding for investigator effort has been provided by K02AA018755, U10AA008401, P50AA022537, and a European Research Council Consolidator Grant (647648 EdGe). The content does not necessarily represent the views of these funding bodies. We would also like to thank the participants and employees of 23andMe, Inc. for making this work possible. We are grateful to Drs. R. Karlsson Linnér and T.T. Mallard for sharing their script for plotting PheWAS results. LJS, original co-Principal Investigator for CSP #572, passed away in February 2021.
Author information
Authors and Affiliations
Consortia
Contributions
TBB, MA and PDH conceived the study. PDH and MA oversaw the study. TBB and PBB were the lead analysts. TBB, PBB, NR, AHF, MA and PDH were involved in interpretation of results. TB. and PBB led the writing of the manuscript, with substantive contributions to the writing from PDH and MA. All authors contributed to and critically reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
PDH has served as a consultant to multiple pharmaceutical companies and device manufacturers on phase 2 or 3 development; this consulting work has been determined to be unrelated to the content of the paper. No other authors report any relevant conflicts of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Bigdeli, T.B., Barr, P.B., Rajeevan, N. et al. Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder. Mol Psychiatry (2024). https://doi.org/10.1038/s41380-024-02472-1
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41380-024-02472-1